🫒
Healthcare & Biotech Myopic Strategy & Over-Diversification 2012 - 2023

Olive AI 医疗自动化:为什么估值 40 亿美元的「AI 自动化」公司,会被发现背后是大量人工操作?

把尚未成熟的能力包装成产品卖出去,再用人力在背后填补差距

Olive AI 医疗自动化:巅峰期医疗流程自动化领域估值最高的独角兽之一,估值一度超过 40 亿美元,获多家顶级机构投资;终局是被曝实际自动化能力远低于宣传、严重依赖人工,医院客户大量退约,公司出售资产并关停。

See the patterns
公开报道整理 待核查 Figures as of 2023 0 sources What do these mean?

How to read this bar

This bar states plainly what we know and what we have checked, so you can judge it yourself.

· Review status: “pending” means no editor has checked it against the sources yet; “checked” means key facts match the sources.

· Figures as of: the year the numbers are current to; later changes are out of scope.

· Sources: listed one by one at the bottom of the page. “Primary” means official filings, annual reports or regulator documents.

· Corrections: every change and its basis is published — nothing is edited silently.

Editorial policy → Editorial policy: the full inclusion rules, verification process, AI disclosure and correction promise.

No English translation for this case yet — showing the stored original.
Peak valuation

医疗流程自动化领域估值最高的独角兽之一,估值一度超过 40 亿美元,获多家顶级机构投资

Final cost

被曝实际自动化能力远低于宣传、严重依赖人工,医院客户大量退约,公司出售资产并关停

Attribution votes

3,788 votes cast

Community output

1 plans · 1 insights

Sponsored
把你亲历的失败写进来

投稿会先进入待审,通过后才进入公开目录和站点地图。

Root Causes Consensus Poll

Vote for the primary fatal error that caused this enterprise to collapse.

战略

产品能力被系统性夸大

宣传中的自动化程度与真实交付差距明显,客户预期被误导

1,246 votes (33%)
资本财务

用人工在后台补位掩盖产品缺陷

人力成本无法随规模摊薄,交付越多亏损越大

1,047 votes (28%)
产品技术

客户续约时暴露真实效果

医院的评估周期较长,问题在续约阶段才集中显现

847 votes (22%)
组织管理

增长目标压过交付质量

为满足融资预期持续签约,交付能力未能同步提升

648 votes (17%)